Ulcerative colitis associated with aplastic anemia

Digestive Diseases and Sciences

Volumn 48, Issue 7, 2003, Pages 1376-1379

  Kishikawa, Hiroshi ^a   Nishida, Jiro ^a   Nakano, Masaru ^a   Hirano, Erika ^a   Morishita, Tetsuo ^a   Ishii, Hiromasa ^b  

^a TOKYO DENTAL COLLEGE   (Japan)

^b KEIO UNIVERSITY   (Japan)

Author keywords

Aplastic anemia; Cyclosporine; HLA DR2; Ulcerative colitis

Indexed keywords

CYCLOSPORIN A; MESALAZINE; PREDNISOLONE; STEROID;

ABDOMINAL PAIN; ADULT; APLASTIC ANEMIA; ARTICLE; BLOOD TRANSFUSION; CASE REPORT; CLINICAL FEATURE; COLONOSCOPY; DIARRHEA; DISEASE ASSOCIATION; HUMAN; MALE; PRIORITY JOURNAL; STEROID THERAPY; THROMBOCYTOPENIA; TREATMENT OUTCOME; ULCERATIVE COLITIS; WEIGHT REDUCTION;

ADULT; ANEMIA, APLASTIC; ANTI-INFLAMMATORY AGENTS; BLOOD TRANSFUSION; BONE MARROW EXAMINATION; COLITIS, ULCERATIVE; CYCLOSPORINE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MESALAMINE; PREDNISOLONE; REMISSION INDUCTION; TREATMENT OUTCOME;

EID: 0038726338     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1024179730817     Document Type: Article

References (22)

1. Retsky JE, Kraft CS: The extraintestinal manifestations of inflammatory bowel disease. In Inflammatory Bowel Disease. JB Kishner, RG Shorer (eds). Baltimore, Williams and Wilkins, 1995, pp 474-491
2. Mir Madjlessi SH, Farmer RG, Weick JK: Inflammatory bowel disease and leukemia. Dig Dis Sci 31:1025-1031, 1986
3. Eng C, Farraye FA, Shulman LN, Peppercorn MA, Krauss CM, Connors JM, Stone RM: The association between the myelodysplastic syndromes and Crohn disease. Ann Intern Med 117:661-662, 1992
4. Harewood GC, Loftus EV Jr, Tefferi A, Tremaine WJ, Sandborn WJ: Concurrent inflammatory bowel disease and myelodysplastic syndromes. Inflam Bowel Dis 5:98-103, 1999
5. Sahay R, Prangnell DR, Scott BB: Inflammatory bowel disease and refractory anemia (myelodysplasia). Gut 34:1630-1631, 1993
6. Hebbar M, Kozlowski D, Wattel S, Mastrini S, Dievart M, Duclos B, Bonaz B, d'Almagne H, Belaiche J, Colombel JF, Fenaux P: Association between myelodysplastic syndromes and inflammatory bowel disease. Report of seven new cases and review of the literature. Leukemia 11:2188-2191, 1997
7. Laidlaw ST, Reilly JT: Antilymphocyte globulin for mesalazine-associated aplastic anemia. Lancet 343:981-982, 1994
8. Nakao S, Takami A, Sugimori N, Ueda M, Shiobata S, Matsuda T, Mizoguchi H: Response to immunosupressive therapy and an HLA-DRB1 allele in patients with aplastic anemia: HLA-DRB1*1501 does not predict response to antithymocyte globulin. Br J Haematol 92:155-158, 1996
9. Chapuis B, Von Fliedner VE, Jeannet M, Merica H, Vuagnat P, Gratwohl A, Nissen C, Speack B: Increased frequency of DR2 in patients with aplastic anemia and increased DR sharing in their parents. Br J Haematol 63:51-57, 1986
10. Nimer SD, Ireland P, Meshkinpour A, Frane M: An increased HLA-DR2 frequency is seen in aplastic anemia patients. Blood 84:923-927, 1994
11. Asakura H, Tsuchiya M, Aiso S, Watanabe M, Kobayashi K, Hibi T, Ando K, Tanaka H, Sekiguchi S: Association of the human lymphocyte-DR2 antigen with Japanese ulcerative colitis. Gastroenterology 82:413-418, 1982
12. Sugimura K, Asakura H, Mizuki N, inoue M, Yagita A, Tsuji K, Inoko H: Analysis of genes within the HLA region affecting susceptibility to ulcerative colitis. Hum Immunol 36:112-118, 1993
13. De la Concha EG, Fernandez-Arquero M, Santa-Cruz S, Lopez-Nava G, Figueredo MA, Diaz-Rubio M, Garcia-Paredes J: Positive and negative associations of distinct HLA-DR2 subtypes with ulcerative colitis. Clin Exp Immunol 108:392-395, 1997
14. Futami S, Aoyama N, Honsako Y, Tamura T, Morimoto S, Nakashima T, Ohmoto A, Okano H, Miyamoto M, Inaba H, Naruse T, Nose Y, Kasuga M: HLA-DRB1*1502 allele, subtype of DR15, is associated with susceptibility to ulcerative colitis and its progression. Dig Dis Sci 40:814-818, 1995
15. Masuda H, Nakamura Y, Tanaka T, Hayakawa S: Distinct relationship between HLA-DR genes and intractability of ulcerative colitis. Am J Gastroenterol 89:1957-1962, 1994
16. Leidenius MH, Koskimies SA, Kellokumpu IH, Hockerstedt KA: HLA antigens in ulcerative colitis and primary sclerosing cholangitis. APMIS 103:519-524, 1995
17. Braegger CP, Nicholls S, Murch SH, Stephens S, MacDonald TT: Tumor necrosis factor alpha in stool as a marker of intestinal inflammation. Lancet 339:89-91, 1992
18. Casini-Raggi V, Kam L, Chong YJT, Fiocchi C, Pizarro TT, Cominelli F: Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease. A novel mechanism of chronic intestinal inflammation. J Immunol 154:2434-2340, 1995
19. Hirayama Y, Kohgo Y, Matsunaga T, Ohi S, Sakamaki S, Niitsu Y: Cytokine mRNA expression of bone marrow stromal cells from patients with aplastic anemia and myelodysplastic syndrome, Br J Haematol 85:676-683, 1993
20. Schultz JC, Shahidi NT: Detection of tumor necrosis factor-alfa in bone marrow plasma and peripheral blood plasma from patients with aplastic anemia. Am J Hematol 45:32-38, 1994
21. Miller LC, Kaplan MM. Serum interleukin-2 and tumor necrosis factor-α in primary biliary cirrhosis: decrease by colchicine and relationship to HLA-DR4. Am J Gastroenterol 87:465-470, 1992
22. Jacob CO, Fronek Z, Lewis GD, Koo M, Hansen JA, McDevitt HO: Heritable major histocompability complex class II-associated differences in production of tumor necrosis factor a: relevance to genetic predisposition to systemic lupus erythematosus, Proc Natl Acad Sci USA 87:1233-1237, 1990